Paradigm Health, a clinical trial matching startup, raised a $78 million Series B and acquired Flatiron Health's clinical research business.
Why it matters: Paradigm is part of a growing group of solutions designed to streamline clinical trials and drug approvals, and Big Pharma has taken note.
